Colgate-Palmolive (NYSE:CL – Get Free Report) had its price target lifted by investment analysts at Barclays from $83.00 to $89.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s target price suggests a potential downside of 3.69% from the company’s previous close.
A number of other analysts have also weighed in on CL. Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. UBS Group cut their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a research note on Friday, March 14th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $102.06.
View Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Stock Up 0.4 %
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm earned $0.87 earnings per share. As a group, analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive announced that its board has approved a share repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s board believes its shares are undervalued.
Institutional Investors Weigh In On Colgate-Palmolive
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $27,000. Vermillion Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth $31,000. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth $32,000. Finally, Briaud Financial Planning Inc bought a new position in Colgate-Palmolive in the 4th quarter worth $32,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- How to Profit From Growth Investing
- How China’s Recovery Could Boost These 3 Platinum Plays
- What is a Death Cross in Stocks?
- Fortinet: A Top Cybersecurity Stock With Growth Catalysts
- 3 Fintech Stocks With Good 2021 Prospects
- 4 Reasons Amazon Stock Can’t Be Ignored Right Now
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.